Home > Insider Trading > Filing (0001127602-20-010317)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Bausch Health Companies Inc.	BHC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1681871	Christina Ackermann	400 Somerset Corporate Boulevard Bridgewater NJ 08807	Evp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares, No Par Value	Disposition	2020-03-09	3,343	$20.96	87,245	No	4	F	Direct
Common Shares, No Par Value	Acquisiton	2020-03-10	4,390	$18.25	91,635	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2020-03-10	4,390	$0.00	96,025	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	P	Direct
No	4	A	Direct

Footnotes

This number represents common shares, no par value, of the Issuer ("Common Shares") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
The price reported above is a weighted average price. This transaction was executed in multiple trades at prices ranging from 18.23 to $18.25. Information regarding the number of shares purchased and the purchase price per share will be provided upon request by the Commission staff, the Issuer or a shareholder of the Issuer.
Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares reported on Table I above, pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the Reporting Person's continued service (except in limited circumstances).